Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 5Thoracic 2Other hematologic neoplasm 2Gynecologic 2Head & Neck 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma 1

Interventions

Paclitaxel 79Carboplatin 66pembrolizumab 61Bevacizumab 56Cisplatin 48Specimen Handling 29Drug Therapy 26Blood Specimen Collection 24Cyclophosphamide 20olaparib 19Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14fludarabine 14Brachytherapy 14Radiotherapy 13abemaciclib 12Topotecan 11Nivolumab 11Injections 11Doxorubicin 11lenvatinib 10Fluorouracil 10atezolizumab 9Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Maintenance × Gynecologic × Clear all
NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Recruiting
300 enrolled
Gynecologic

Carcinoma, Ovarian Neoplasms

NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
167 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡